期刊文献+

沙利度胺联合DVD方案治疗老年难治性多发性骨髓瘤的疗效观察 被引量:4

下载PDF
导出
摘要 目的探讨沙利度胺联合DVD方案(T-DVD)治疗老年难治性多发性骨髓瘤(MM)的临床疗效。方法 40例老年难治性MM给予DVD方案:长春新碱0.4 mg/d,静脉滴注,第1~4天;脂质体阿霉素40 mg/m2,静脉滴注,第1天;地塞米松30mg/d,静脉滴注,第1~4天、第9~12天和第17~20天。28d为1疗程,共3个疗程。沙利度胺起始剂量为100 mg/d,每周增加50 mg/d,最大剂量为200 mg/d,持续12周以上。结果完全缓解6例,部分缓解11例,微小反应4例,无反应14例,疾病进展5例,总有效率为52.50%。治疗相关不良反应为1~2级均可耐受。结论沙利度胺联合DVD方案对老年难治MM患者有效率高、耐受性好及不良反应少等特点,是老年难治性MM患者的理想选择。
作者 苗文春
机构地区 绍兴第二医院
出处 《现代实用医学》 2011年第2期187-188,共2页 Modern Practical Medicine
  • 相关文献

参考文献6

  • 1Blade J, Samson D, Reeee D, et al. Cri- teria for evaluating disease response and progression in patients with multiple my- eloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant [J]. Br J Haematol, 1998,102 (5):1115-1123.
  • 2万理萍,孙汉英,刘文励.多发性骨髓瘤预后因素分析[J].临床血液学杂志,1999,12(6):281-283. 被引量:5
  • 3Zervas K, Mihou D, Katodritou E, et al.VAD-doxil versus VAD-doxil plus thal- idomide as initial treatment for multiple myeloma: results ofa multicenter randomi- ,zed trial of the Greek Myeloma Study Group [J]. Ann Oncol, 2007,18(8):1369- 1375.
  • 4Chanan-Khan AA, Lee K. Pegylated lipo- somal doxorubicin and immunomodul- atory drug combinations in multiple myel- oma: rationale and clinical experience [J]. Clin Lymphoma Myeloma, 2007,7(Suppl 4):$163-169.
  • 5Baz R, Walker E, Karam MA, et al.Len- alidomide and pegylated liposomal dox- orubicin based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy [J]. Ann Oncol, 2006,17(12): 1766-1771.
  • 6Offidani M, Corvatta L, Piersantelli MN, et al. Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma [J]. Blood, 2006,108(7):2159-2164.

共引文献4

同被引文献33

  • 1丁丽,朱建平,邵力正,徐鸣.CIK细胞与VD方案治疗老年复发/难治性多发性骨髓瘤的临床观察[J].中国医药生物技术,2013,8(6):429-432. 被引量:6
  • 2李睿,张莉,徐泽锋,高辉,聂能,肖志坚.沙利度胺加联合化疗治疗恶性浆细胞疾病的疗效和不良反应[J].白血病.淋巴瘤,2006,15(1):16-19. 被引量:10
  • 3Alexanian R,Dimopoulos MA,Delasalle K,et al.Primary dexamet hasone t reatment of multiple myeloma[J].Blood,1992,80(4):887-890.
  • 4Rahjumar SV,Rosiol L,Hussein W,et al.Multicenter,randomized,doubleblind,placebo controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myeloma[J].J Clin Oncol,2008,26(13):2171-2177.
  • 5Barlogie B,Tricot G,Rasmussen E,et al.Total therapy 2 without thalidomide in comparison with total therapy 1:role of intensified induction and posttransplantation consolidation therapies[J].Blood,2006,107(7):2633-2638.
  • 6Zervas K, Dimopoulos MA, Hatzicharissi E, et al. Primary treatment of multiple myeloma with thalidomide, vincristine, liposomal doxorubicin and dexamehasone ( T-VAD doxil) : a phase IT muhicenter study. Ann Oncol, 2004, 15: 134-138.
  • 7Zervas K, Mihou D, Katodritou E, et al. VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for muhiple yeloma: results of a multicenter randomized trial of the Greek Myeloma Study Group. Ann Oncol, 2007, 18: 1369-1375.
  • 8Gobizon. A comparative lomg term study of the toxicity of free and liposome associated doxorubicin in mice after intravenous administration. J Natl Cancer Inst, 1986, 77: 459-469.
  • 9赵变锋,万鼎铭.沙利度胺抗肿瘤机制及临床研究进展[J].内科急危重症杂志,2011,17(1):50-51. 被引量:14
  • 10何群,江薇,朱宇,蔡继明,徐少毅.沙利度胺联合改良VAD+M方案治疗多发性骨髓瘤临床观察[J].浙江实用医学,2011,16(1):26-27. 被引量:1

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部